A5078607463- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Heart Failure Treatment and Management
- Cardiac Arrest and Resuscitation
- Cardiac pacing and defibrillation studies
- Cardiac Valve Diseases and Treatments
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Sarcoidosis and Beryllium Toxicity Research
- Infective Endocarditis Diagnosis and Management
- Pulmonary Hypertension Research and Treatments
- Transplantation: Methods and Outcomes
- Viral Infections and Immunology Research
- COVID-19 Clinical Research Studies
- Intensive Care Unit Cognitive Disorders
- COVID-19 and healthcare impacts
- Hemodynamic Monitoring and Therapy
- Vasculitis and related conditions
- Chronic Lymphocytic Leukemia Research
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Drug-Induced Ocular Toxicity
- Trauma and Emergency Care Studies
- Bariatric Surgery and Outcomes
- Cardiac Arrhythmias and Treatments
- Congenital heart defects research
Rochester General Hospital
2018-2024
Unity Health System
2017-2024
Regional Health
2023
Regional Medical Center
2021-2022
Weiss Memorial Hospital
2021
North Shore University Hospital
2021
Kyushu University
2021
Lourdes Hospital
2021
Parallax Research (United States)
2021
University of Rochester Medical Center
2020
Left ventricular assist devices serve as a salvage therapy for patients with advanced heart failure. Complications such thrombosis and obstruction can lead to acute device malfunction, posing significant clinical risks. A multidisciplinary approach is crucial management. Few cases in the literature have demonstrated safety efficacy of percutaneous intervention, which holds value due its less invasive nature minimal risk morbidity, especially high-risk surgical patients.
Abstract Cardiogenic shock from biventricular failure that requires acute mechanical circulatory support carries high 30 day mortality. Acute can serve as bridge to orthotopic heart transplant (OHT) in selected patients. We report a patient with secondary rapidly progressive cardiac sarcoidosis refractory medical management who was bridged OHT Impella 5.0 and RP—temporary left right ventricular assist devices, respectively. This is the first successful transplantation using these devices...
Abstract Purpose of Review Heart failure (HF) management guided by hemodynamics obtained from an implantable pulmonary artery pressure (PAP) sensor (CardioMEMS) improves symptoms and reduces HF hospitalizations (HFH). This paper reviews the theoretical basis vascular physiology, summarizes recently published data about CardioMEMS, provides practical guidelines for patient selection management. Recent Findings Compared to patients managed standard care, randomized PAP-guided treatment have a...
Driveline infection (DLI) is a significant source of morbidity and mortality during left ventricular assist device (LVAD) support yet limited studies are available to describe the center-level prevalence, preventive practices, their potential effectiveness.We surveyed LVAD centers in United States determine program burden practices for DLI HeartMate (HM) 3 support. An online, anonymous, question-based survey was sent expert providers at implanting centers. Only single respondent completed...
McLeod's syndrome (MLS) is an X-linked disorder caused by mutations in the XK gene with neurological manifestations as well cardiomyopathy. This a case of acute exacerbation heart failure 44-year-old White male confirmed diagnosis MLS, which was managed guideline-directed medical therapy and placement implantable cardioverter defibrillator recovery ejection fraction.
Background To examine the diagnostic accuracy of cardiac magnetic resonance imaging (CMR) in differentiating thrombus from myxoma Thrombus is thought not to enhance on CMR, myxomas are show mild heterogenous enhancement delayed imaging. It sometimes difficult differentiate them, and this may lead misdiagnosis, which would significantly impact treatment. Thrombi can have varying signal intensities depending their age fibrous composition T1 T2
Hypereosinophilic syndrome comprises a diverse and intricate array of rare disorders, exhibiting clinical manifestations that extend across various medical subspecialties. Within its myeloid form, chronic eosinophilic leukemia represents malignancy characterized by severe hematological complications distinctive organ dysfunction, notably affecting the cardiovascular system. This report presents case Loeffler with an initial presentation ventricular tachycardia.
It remains unknown whether the concomitant coronary chronic total occlusion (CTO) would affect outcomes of Mitral valve Trans-catheter Edge to edge-to-edge repair (M-TEER) procedure.
Abstract Background Congestive heart failure has reached pandemic levels, and left-ventricular assist devices (LVAD) are increasingly used to treat refractory failure. Infection is a leading complication of LVADs. Despite numerous reports (most being retrospective), several knowledge gaps pertaining the epidemiology burden an LVAD-associated infection (LVADi) remain. We sought address these using prospective, case-control design. Methods All patients who received LVAD from November 1, 2018...